Related Experiment Video
Updated: Jul 15, 2025

09:49
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
16.0K
Prophylactic platelet transfusion response in critically ill patients: a prospective multicentre observational study
Florian Reizine1,2, Sarah Le Marec3, Anthony Le Meur4
1Maladies Infectieuses Et Réanimation Médicale, CHU de Rennes, Rennes, France.
Critical Care (London, England)
|September 27, 2023
Summary
Critically ill patients often have poor response to prophylactic platelet transfusions, with nearly three-quarters experiencing suboptimal increments. Platelet storage duration is a key factor for intervention.
Area of Science:
- Critical Care Medicine
- Hematology
- Transfusion Medicine
Background:
- Prophylactic platelet transfusions are common in critically ill patients but response can be inconsistent.
- Optimizing transfusion practices is crucial for improving patient outcomes.
Purpose of the Study:
- To describe prophylactic platelet transfusion response in critically ill patients.
- To identify factors associated with suboptimal response.
- To determine the impact of poor response on clinical outcomes.
Main Methods:
- Prospective multicentre observational study of 472 prophylactic platelet transfusions in intensive care units.
- Poor response defined as corrected count increment (CCI) < 7 at 18-24 hours post-transfusion.
- Mixed-effect model used to assess factors associated with poor response.
Main Results:
- 73.9% of transfusions and 77.9% of patients showed a poor platelet transfusion response.
- Factors associated with poor response included hematological malignancy, sepsis, higher SOFA score, and longer platelet storage duration.
- Hemoglobin and BMI were associated with better response.
Conclusions:
- Suboptimal platelet increment is frequent following prophylactic transfusions in critically ill patients.
- Platelet storage duration is an intervention-accessible factor linked to poor response.
- Clinical outcomes did not significantly differ based on transfusion response.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
552
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
552
Formation of the Platelet Plug
6.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.6K
Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K

